BAS Research Announces Exclusive License of James Henry SF
The licensing partnership between BAS Research and James Henry SF underscores both company's commitments to responsibly utilize the medicinal and therapeutic benefits of CBD and THC
BERKELEY, Calif. - June 6, 2018 (Investorideas.com Newswire) BAS Research, California's first licensed cannabis manufacturing company developing advanced science-driven cannabis oil and extraction services, is pleased to announce that it has entered into a licensing agreement ("the Agreement") with James Henry SF, a lifestyle cannabis brand based in San Francisco, California.
"We are thrilled to partner with BAS Research. We were immediately drawn in by BAS Research's mission to 'heal the world', which dovetails seamlessly with our own goals for James Henry SF," said James Victor, Co-Founder, James Henry SF. "We have worked attentively to blend pharmaceutical science and social compassion, and are proud to provide products of the highest quality and safety to consumers throughout California."
"BAS Research shares James Henry'scommitment to developing the purest, safest and most advanced cannabis products. This made partnering together a natural choice," said John Adams, Co-founder, James Henry SF, "BAS Research's quad-testing protocols and manufacturing standards are incredible and we are excited to have them manufacture our products to the masses."
James Henry has created a unique line of CBD and THC combination products that can be selected for relief during any time of the day. Daytime Focus is a high CBD formulation, ideal for new consumer experiences, anxiety relief, and focus. Evening Social is a THC-dominant formulation, perfect for happy hour with friends and other social occasions. Weekend Retreat is a full THC formulation designed for experienced consumers and patients seeking effective pain relief.
"BAS Research is pleased to be working with the James Henry Brand," said Dr. Bao Le, CEO, BAS Research. "We are exceptionally scrupulous when selecting brands to partner with. James Henry SF embodies all of the qualities we look for when aligning with a new product."
BAS Research recently announced the launch of the BASInfused™ certification seal. This seal will be placed on all James Henry's products, which will help consumers identify any cannabis products that contain BAS advance science-driven oil and have therefore met the arduous standards required to ensure the safety and purity of the product.
About BAS Research
BAS Research is California's first licensed cannabis manufacturing company developing advanced science-driven cannabis oil and extraction services. We provide a variety of services to clients, including compliance, product development, formulation, extraction, contract manufacturing, and fulfillment. Founded by veterans of the cannabis, pharmaceutical and technology industries, the company manufactures high-quality cannabis products with a focus on superior innovation, integrity and socially responsible production processes. BAS recently launched the BASInfused ™certification program, which allows consumers to clearly distinguish rigorously tested BAS products by way of a seal on both the packaging and storefront. For more information about BAS Research or BASInfused products, visit our website or follow us on Facebook @basresearch, Twitter @bas_research, Instagram @basresearch or LinkedIn @bas-research.
About James Henry Brand:
The James Henry SF team takes pride in possessing the most potent, uncut disposable cannabis products in the marketplace. Our products are carefully curated from seed-to-sale, with pesticide-free flower sources that undergo various checkpoints during the CO2 extraction and distillation processes. Our products contain no additives, no fillers, and no carrier oils.
Marijuana / Hemp Stocks
At Cannabisinvestorideas.com and Investorideas.com
Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.